埃沃特克任命迪特·维纳德为监事会主席. Evotec names Dieter Weinand new Supervisory Board Chairman.

埃沃特克公司提名了Dieter Weinand,M.S.,作为其新的监事会主席,在2026年年度股东大会上接替Iris Löw-Friedrich教授博士. Evotec SE has nominated Dieter Weinand, M.S., as its new Supervisory Board Chairman, succeeding Prof. Dr. Iris Löw-Friedrich at the 2026 Annual General Meeting. 这一领导层的变化旨在支持公司转型,提高效率,商业执行和利能力. This leadership change aims to support the company's transformation toward greater efficiency, commercial execution, and profitability. 韦南德拥有30多年的经验, 在拜耳和瑞等大制药公司担任过高层职务. Weinand brings over 30 years of experience from top roles at major pharmaceutical companies like Bayer and Pfizer.